Navigation Links
Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency

THE WOODLANDS, Texas, June 08, 2007 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. today announced the publication of new findings from a joint research project with scientists at Fox Chase Cancer Center in Philadelphia, PA. Together with David L. Wiest, Ph.D., Lexicon researchers have discovered a novel and surprising role for ribosomal protein L22 (Rpl22) in the development of T lymphocytes. These findings have been published in the June issue of the journal Immunity.

Dr. Wiest and scientists at Lexicon Pharmaceuticals discovered that deletion of the ubiquitously expressed Rpl22 gene resulted in the up-regulation of p53, a key tumor suppressor gene that triggers apoptosis and cell death. Further, it was determined that this up-regulation of p53 was responsible for blocking alpha-beta+ T cell development thereby creating an immune-deficient state.

"The connection between Rpl22 and the p53-mediated apoptosis pathway is very exciting," said Dr. David Wiest, Member, Basic Science Division at Fox Chase Cancer Center. "If research confirms our theories, Rpl22 may prove to be an important biomarker for certain T cell immune deficiency diseases and some types of lymphoid cancers."

Rpl22 is one of several proteins that comprise the large subunit of eukaryotic ribosomes, cellular complexes that are responsible for translating messenger RNA and assembling proteins. Although not-required for translation, Rpl22 may play a role in protein synthesis or macromolecular assembly that is important for some cell types, but not others.

"These findings could help us to further define the pathways involved in T lymphocyte development and regulation," said Dr. Tamas Oravecz, Lexicon's Vice President of Immunology and Oncology. "While Rp122 will likely prove difficult for development as a classic drug target, understanding its role could contribute significantly to its potential as a biomarker for
'"/>




Page: 1 2 3

Related medicine technology :

1. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
2. Lexicon-Genentech Collaboration Yields Potential Therapeutic Targets
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:3/31/2015)... DUBLIN , Mar. 30, 2015 Research ... announced the addition of the "Eurpoean Automatic ... Fully-Automated), End-User (Pre-Hospitals, Public Access Market, Hospitals, Alternate ... report to their offering. The European ... grow at a CAGR of 10.9% from 2014 ...
(Date:3/31/2015)... , March 31, 2015  The efficacy of ... highlighted in a recently published study 1 of ... prevention research team, including Curtis Donskey , M.D.  ... run for the same length of time from the ... (PU-UV) unit.  The results showed surprisingly low pathogen kill ...
(Date:3/31/2015)... DALLAS , March 31, 2015 ... H1 2015" therapeutic market research report of 68 ... its online business intelligence library. The ... information on the therapeutic development for Pemphigus ... therapeutics assessment by drug target, mechanism of action ...
Breaking Medicine Technology:Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 2VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 3VA Funded Study Validates Continuous UV-C Technology For Pathogen Reduction 4Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4
... antibody successfully targets human leukemic stem cells, ... company, has today presented data at the American ... the promising,pre-clinical activity of a novel monoclonal antibody, ... AML is an aggressive cancer of white ...
... Scientific Presentations Detail Progress with VeraTag(TM) Assays in Breast ... ... (Nasdaq: MGRM ) today announced five posters to be,presented at the 30th ... - 16, 2007. Following are details for,each embargoed session:, -- Friday, ...
Cached Medicine Technology:Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML) 2Preclinical Studies Show Promise for Novel Antibody Therapy to Treat Acute Myeloid Leukemia (AML) 3Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 2Monogram Announces Posters to be Presented at the 30th San Antonio Breast Cancer Symposium 3
(Date:3/31/2015)... March 31, 2015 Calling all runners, walkers ... and other tick-borne diseases! The first annual “Lyme Walk & ... Park in Stamford, CT. The event, hosted by Lyme ... will raise funds to support research and education about Lyme ... to all ages and abilities, will feature 5K and 10K ...
(Date:3/31/2015)... March 31, 2015 Many people, including ... basketball, rock climbing, and cycling are only for able-bodied ... at Memorial Rehabilitation Institute aims to change that thinking. ... System, will host an Adaptive Sports Expo on Saturday, ... Regional Hospital South in Hollywood. , The event ...
(Date:3/31/2015)... 31, 2015 Indosoft, developer of the Q-Suite ... support in development of their 5.x line. The industry ... been deployed around the world for more than a decade. ... a telephony platform, Q-Suite can fully embrace newer Asterisk features ... center software on Asterisk for more than a decade. The ...
(Date:3/31/2015)... KL Malaysia (PRWEB) March 31, 2015 ... need and requirement for education in a drastically different ... way in which learning and training content is being ... is being impacted by technology in an unprecedented way ... everyone, said Wemel Cumavoo, co-founder and CEO, My Mobile ...
(Date:3/31/2015)... The Walk a Mile Project, as part of their documentary ... their 3rd research sequence. The new sequence focuses on ... was and is a massive component of GMO regulation in ... World Films. “We started our research by going way ... food supply, just to get a bird's eye and big ...
Breaking Medicine News(10 mins):Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:Memorial Healthcare System's Adaptive Sports Expo Encourages Physically Challenged To Go Beyond Perceived Limitations 2Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 2Health News:LTT Global Communications Launches First Asia Holistic Online Learning Platform 3Health News:The Walk a Mile Project Launches New Research Sequence on Substantial Equivalence of GMOs 2
... Researchers at North Carolina State University have successfully modified ... specific cells inside the human body, without affecting surrounding ... of times smaller than the width of a human ... with greatly reduced, or even eliminated, side effects. , ...
... 12 Harris Corporation,(NYSE: HRS ... has been awarded a ten-year contract by ... to provide network,management and IT services for ... First Infrastructure Services (HFIS) contract includes,software and ...
... Feb. 12 When an emergency squad pulls up to ... New York, chances are the paramedics have received a new ... the University of Rochester Medical Center.The institution is ... (EMTs) and paramedics with video podcast lessons downloadable onto iPods ...
... in blindness and crumbling teeth have found a single ... tooth development. , A previously undiscovered and ... has been uncovered by researchers from the University of ... village in the war-torn Gaza strip. , Funded ...
... The Terri Lynne Lokoff Child Care Foundation (TLLCCF) ... TYLENOL(R) National Child Care Teacher Awards(TM). Fifty exemplary ... the United States and on U.S. Military bases in ... to maintaining high-quality child care practices and dedication to ...
... the body quickly needs to restore the vital blood volume. ... in the bone marrow. These hematopoietic stem cells remain dormant ... case of injury and loss of blood. Then they immediately ... cells. This has recently been shown by a group of ...
Cached Medicine News:Health News:Nanoparticle 'smart bomb' targets drug delivery to cancer cells 2Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 2Health News:Health First Healthcare System Awards Harris Corporation Enterprise-wide Network Management and IT Services Contract 3Health News:University of Rochester Launches iTraining for Emergency Responders 2Health News:Gaza strip families give first clue to condition causing blindness and tooth decay 2Health News:Terri Lynne Lokoff Child Care Foundation Announces Recipients of the 2009 Terri Lynne Lokoff/Children's TYLENOL(R) National Child Care Teacher Awards(TM) 2Health News:Stem cells: Deathly awakening by interferon 2
... Leica ASP300 smart tissue processor features superior ... ASP300 is a fully enclosed, stand-alone system ... samples. This new tissue processor combines proven ... touch screen and easy to use,yet powerful ...
... 120 represents a new tissue infiltration instrument, ... a masterly way. The robust caroussel design ... smallest space. The instrument includes either 10 ... reagent and 3 paraffin containers. Up to ...
... electronic, motorized rotary microtomes ... applications of paraffin, semi-thin ... specimens in clinical, research, ... instruments display extra-ordinary ergonomic ...
... heavy-duty sectioning system is the standard microtome for ... real working animal. ,Large specimens up to 250 ... bone or teeth and whole organs (brain, lung, ... accessories, specially designed for paraffin and resin embedded ...
Medicine Products: